InvestorsHub Logo
Followers 3
Posts 104
Boards Moderated 0
Alias Born 11/03/2009

Re: None

Monday, 02/19/2018 2:03:17 PM

Monday, February 19, 2018 2:03:17 PM

Post# of 14936
This was from Chen Lin who has followed SRNE for a few years now.


Sorrento Therapeutics, Inc. (SRNE) made CNBC as they were discussing Celularity yesterday! You can see they mentioned SRNE at the end of the video. Celularity raised 250 million recently and SRNE's 25% probably worth the current market cap after its planned IPO. Right now investors are only warming up for Celularity, they have no idea that SRNE owns so much % of the Celularity. But they will find out soon from the S-1 filing of Celularity as it goes forward to IPO. I feel it is likely a replay of the NK IPO 3 years ago and I feel 20+ is very possible in the summer if the IPO goes successfully and everything else is on track for SRNE.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNEQ News